Eric Snijder to Drug Design
This is a "connection" page, showing publications Eric Snijder has written about Drug Design.
Connection Strength
0.057
-
a-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment. J Med Chem. 2020 05 14; 63(9):4562-4578.
Score: 0.021
-
Design, Synthesis, and Anti-RNA Virus Activity of 6'-Fluorinated-Aristeromycin Analogues. J Med Chem. 2019 07 11; 62(13):6346-6362.
Score: 0.020
-
Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity. Bioorg Med Chem Lett. 2015 Aug 01; 25(15):2923-6.
Score: 0.015